サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1781990

自己血糖測定機器市場：製品タイプ別、技術別、検査部位別、患者タイプ別、エンドユーザー別、国別、地域別：世界産業分析、市場規模、市場シェア、2025～2032年予測

Self-monitoring Blood Glucose Devices Market, By Product Type, By Technology, By Testing Site, By Patient Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
自己血糖測定機器市場：製品タイプ別、技術別、検査部位別、患者タイプ別、エンドユーザー別、国別、地域別：世界産業分析、市場規模、市場シェア、2025～2032年予測
出版日: 2025年07月04日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

自己血糖測定機器市場規模は2024年に197億5,201万米ドルとなり、2025～2032年にかけてCAGR 11.53%で拡大

血糖自己測定機器市場-市場力学

糖尿病有病率の上昇と技術革新が自己血糖測定機器の需要を押し上げる

糖尿病有病率の上昇と急速な技術革新が相まって、自己血糖測定機器の世界の普及が進んでいます。国際糖尿病連合は、世界の成人の約10人に1人が糖尿病を患っていると報告しており、効果的なセルフケアツールの緊急の必要性を強調しています。非侵襲性センサやモバイルアプリの統合などの進歩により、血糖値モニタリングはより便利で正確になってきています。米国疾病予防管理センター（CDC）は、定期的な血糖モニタリングが合併症を大幅に減らし、糖尿病患者の生活の質を改善することを強調しています。さらに、インドやブラジルのような国では、政府の医療プログラムが補助金や啓発キャンペーンを通じてこれらの機器へのアクセスを増加させており、何百万人もの患者がより効果的に病状を管理し、ヘルスケアシステムの負担を軽減するのに役立っています。

自己血糖測定機器市場-主要な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025～2032年）に約11.53％のCAGRで年間成長すると推定されます。

製品タイプ別では、自己血糖測定（SMBG）メータが2024年に最大市場シェアを示すと予測されます。

技術別では、2024年には電気化学技術が主要技術でした。

検査部位別では、指先が2024年の主要検査部位です。

患者タイプ別では、2024年は2型糖尿病がトップ

エンドユーザー別では、2024年の主要エンドユーザーは在宅医療でした。

地域別では、北米が2024年の売上高でトップ

血糖自己測定機器市場-セグメンテーション分析

自己血糖測定機器の世界市場は、製品タイプ、技術、検査部位、患者タイプ、エンドユーザー、地域に基づいて区分されます。

市場は製品タイプに基づいて4つのカテゴリーに分けられます。自己血糖測定器（SMBG）、検査ストリップ、ランセット、持続グルコースモニタです。血糖自己測定（SMBG）メーターは、デジタル測定値による便利な追跡を提供し、検査ストリップは正確さと迅速な結果を保証します。ランセットは採血に不可欠で、不快感を最小限に抑えることができます。持続血糖モニターはリアルタイムのグルコース追跡を可能にし、より良い糖尿病管理のための牽引役となっています。

市場は技術によって2つのカテゴリーに分けられます。電気化学式と測光式です。電気化学的技術は、その精度、携帯性、費用対効果から優位を占めており、SMBG機器によく使用されています。測光技術はあまり普及していないが、視覚的な明瞭さと解釈のしやすさが評価され、初期のモデルや特定の臨床応用によく利用されています。

自己血糖測定機器市場-地理的洞察

血糖自己測定機器市場は、ヘルスケアインフラ、糖尿病有病率、技術導入の影響を受ける地域力学を示します。北米は先進的ヘルスケアシステムと高い糖尿病罹患率でリードし、グルコースモニタリングデバイスの需要を牽引しています。次いで欧州が、強固なヘルスケア施策と糖尿病人口の多さを特徴としています。アジア太平洋は、糖尿病有病率の増加、ヘルスケアインフラの改善、糖尿病管理に対する意識の高まりにより急成長を遂げています。中国、インド、日本のような国々がこの拡大の最前線にいます。ラテンアメリカと中東・アフリカは、ヘルスケアへのアクセスの改善と健康意識の高まりに支えられ、これらの技術を徐々に導入しつつあります。全体として、市場の成長は、地域によるヘルスケアの優先順位、経済状況、糖尿病に関連する健康課題への取り組みの緊急性によって形成されます。

自己血糖測定機器市場-競合情勢

自己血糖測定（SMBG）機器市場は、既存参入企業と新興イノベーターによる激しい競争が特徴です。Abbott Laboratories、Dexcom、Roche Diagnostics、LifeScan、Ascensia Diabetes Careなどの主要企業は、先進技術と広範な販売網で市場を独占しています。AbbottのFreeStyle Libreシリーズは、そのセンサ技術と手頃な価格でグルコースモニタリングに革命を起こし、DexcomのG6とG7システムは、その精度とユーザーフレンドリーなデザインで有名です。RocheのAccu-Chekシリーズは、信頼性とデジタルヘルスプラットフォームとの統合を重視し、多くの人に信頼され続けています。LifeScanのOneTouch製品は、シンプルさと正確さを追求した設計で、幅広いユーザー層に対応しています。AscensiaのContourシリーズは、信頼性とユーザーフレンドリーなデザインで知られています。また、アスリートと健康志向の消費者の両方を対象にした持続血糖測定器Ultrahuman M1を発売したUltrahumanのような新規参入企業も市場に参入しています。戦略的提携、技術の進歩、ユーザー中心の設計への注力は、SMBG機器市場の競争と革新を促進する主要因です。

目次

第1章 自己血糖測定機器市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 自己血糖測定機器の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 自己血糖測定機器産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 自己血糖測定機器市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 自己血糖測定機器市場情勢

  • 自己血糖測定機器市場シェア分析（2024年）
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 自己血糖測定機器市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 自己血糖測定器（SMBG）
    • 検査ストリップ
    • ランセット
    • 持続グルコースモニタ

第8章 自己血糖測定機器市場-技術別

  • 概要
    • 技術別セグメントシェア分析
    • 電気化学式
    • 測光式

第9章 自己血糖測定機器市場-検査部位別

  • 概要
    • 検査部位別セグメントシェア分析
    • 指先
    • 代替部位検査

第10章 自己血糖測定機器市場-患者タイプ別

  • 概要
    • 患者タイプ別セグメントシェア分析
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病

第11章 自己血糖測定機器市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 外来手術センター
    • 診断センター
    • 在宅医療
    • その他

第12章 自己血糖測定機器市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析-自己血糖測定機器産業

  • 競合ダッシュボード
    • 競合ベンチマーキング
    • 競合ポジショニング
  • 企業プロファイル
    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • ARKRAY, Inc.
    • Ascensia Diabetes Care
    • B. Braun Melsungen AG
    • Bayer AG
    • Dexcom, Inc.
    • Eli Lilly and Company
    • GlucoMe
    • i-SENS, Inc.
    • LifeScan, Inc.
    • Medtronic plc
    • Nipro Corporation
    • Nova Biomedical
    • PHC Holdings Corporation
    • Roche Diagnostics
    • Sanofi
    • Terumo Corporation
    • Trividia Health, Inc.
    • Ypsomed Holding AG

第14章 アナリストの全方位展望

目次
Product Code: ANV5438

REPORT HIGHLIGHT

Self-monitoring Blood Glucose Devices Market size was valued at US$ 19,752.01 Million in 2024, expanding at a CAGR of 11.53% from 2025 to 2032.

The Self-monitoring Blood Glucose Devices Market involves portable devices that enable individuals to measure their blood glucose levels independently, playing a crucial role in diabetes management worldwide. Rising diabetes prevalence and increasing awareness about self-care practices are expanding the demand for these devices. According to the World Health Organization, over 422 million people globally are affected by diabetes, emphasizing the importance of regular glucose monitoring. However, challenges such as high costs of advanced devices and limited accessibility in low-income regions can hinder widespread adoption. Opportunities lie in technological advancements like continuous glucose monitoring integration, non-invasive sensors, and smartphone connectivity, which improve user experience and data accuracy. Additionally, growing government initiatives promoting diabetes screening and management are enhancing market penetration, especially in developing countries where early diagnosis and consistent monitoring can significantly improve patient outcomes.

Self-monitoring Blood Glucose Devices Market- Market Dynamics

Rising diabetes prevalence and tech innovations to boost self-monitoring glucose device demand

Rising diabetes prevalence combined with rapid technological innovations is driving greater adoption of self-monitoring blood glucose devices globally. The International Diabetes Federation reports that approximately 1 in 10 adults worldwide lives with diabetes, underscoring the urgent need for effective self-care tools. Advances such as non-invasive sensors and mobile app integration are making glucose monitoring more convenient and accurate. The U.S. Centers for Disease Control and Prevention (CDC) emphasizes that regular blood glucose monitoring can significantly reduce complications and improve quality of life for diabetic patients. Furthermore, government health programs in countries like India and Brazil are increasing access to these devices through subsidies and awareness campaigns, helping millions manage their condition more effectively and reducing the burden on healthcare systems.

Self-monitoring Blood Glucose Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.53% over the forecast period (2025-2032)

Based on product type segmentation, Self-Monitoring Blood Glucose (SMBG) Meters were predicted to show maximum market share in the year 2024

Based on Technology segmentation, Electrochemical technology was the leading Technology in 2024

Based on Testing Site segmentation, Fingertip was the leading Testing Site in 2024

Based on Patient Type segmentation, Type 2 Diabetes was the leading Patient Type in 2024

Based on end user segmentation, Home Care was the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Self-monitoring Blood Glucose Devices Market- Segmentation Analysis:

The Global Self-monitoring Blood Glucose Devices Market is segmented on the basis of Product Type, Technology, Testing Site, Patient Type, End User, and Region.

The market is divided into four categories based on product type: Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets, and Continuous Glucose Monitors. Self-Monitoring Blood Glucose (SMBG) Meters offer convenient tracking with digital readings, while Test Strips ensure accuracy and quick results. Lancets are vital for blood sampling, offering minimal discomfort. Continuous Glucose Monitors enable real-time glucose tracking, gaining traction for better diabetes management.

The market is divided into two categories based on Technology: Electrochemical and Photometric. Electrochemical technology dominates due to its precision, portability, and cost-effectiveness, commonly used in SMBG devices. Photometric technology, though less prevalent, is valued for its visual clarity and ease of interpretation, often utilized in earlier models and specific clinical applications.

Self-monitoring Blood Glucose Devices Market- Geographical Insights

The Self-Monitoring Blood Glucose Devices Market exhibits regional dynamics influenced by healthcare infrastructure, diabetes prevalence, and technological adoption. North America leads with advanced healthcare systems and high diabetes rates, driving demand for glucose monitoring devices. Europe follows, characterized by robust healthcare policies and a significant diabetic population. The Asia-Pacific region is experiencing rapid growth due to increasing diabetes prevalence, improving healthcare infrastructure, and rising awareness about diabetes management. Countries like China, India, and Japan are at the forefront of this expansion. Latin America and the Middle East & and Africa are gradually adopting these technologies, supported by improving healthcare access and rising health awareness. Overall, the market's growth is shaped by regional healthcare priorities, economic conditions, and the urgency of addressing diabetes-related health challenges.

Self-monitoring Blood Glucose Devices Market- Competitive Landscape:

The Self-Monitoring Blood Glucose (SMBG) Devices Market is characterized by intense competition among established players and emerging innovators. Leading companies such as Abbott Laboratories, Dexcom, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care dominate the market with their advanced technologies and extensive distribution networks. Abbott's FreeStyle Libre series has revolutionized glucose monitoring with its sensor technology and affordability, while Dexcom's G6 and G7 systems are renowned for their accuracy and user-friendly design. Roche's Accu-Chek line continues to be a trusted choice for many, emphasizing reliability and integration with digital health platforms. LifeScan's OneTouch products are designed for simplicity and accuracy, catering to a broad user base. Ascensia's Contour series is known for its reliability and user-friendly design. The market is also witnessing the entry of new players like Ultrahuman, which launched its continuous glucose monitor, Ultrahuman M1, targeting both athletes and health-conscious consumers. Strategic collaborations, technological advancements, and a focus on user-centric designs are key factors driving competition and innovation in the SMBG devices market.

Recent Developments:

In July 2024, Roche received CE Mark for its Accu-Chek SmartGuide(R) continuous glucose monitoring (CGM) device. Designed for adults with type 1 and type 2 diabetes, it offers real-time glucose readings and AI-powered predictive alerts for improved self-management.

In May 2024, Intuity Medical and embecta have announced a commercial collaboration to expand access to Intuity's POGO Automatic(R) Blood Glucose Monitoring System, aiming to enhance self-monitoring options and diabetes care for patients across the United States.

In April 2023, Astellas and Roche Diabetes Care Japan partnered to develop and commercialize an integrated diabetes self-management solution featuring Roche's blood glucose monitoring devices and the BlueStar digital health platform, aiming to improve diabetes care in Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care
  • B. Braun Melsungen AG
  • Bayer AG
  • Dexcom, Inc.
  • Eli Lilly and Company
  • GlucoMe
  • i-SENS, Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • PHC Holdings Corporation
  • Roche Diagnostics
  • Sanofi
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Self-Monitoring Blood Glucose (SMBG) Meters
  • Test Strips
  • Lancets
  • Continuous Glucose Monitors

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Electrochemical
  • Photometric

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TESTING SITE- MARKET ANALYSIS, 2019 - 2032

  • Fingertip
  • Alternate Site Testing

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostics Center
  • Home Care
  • Other

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Self-monitoring Blood Glucose Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Self-monitoring Blood Glucose Devices Market Snippet by Product Type
    • 2.1.2. Self-monitoring Blood Glucose Devices Market Snippet by Technology
    • 2.1.3. Self-monitoring Blood Glucose Devices Market Snippet by Testing Site
    • 2.1.4. Self-monitoring Blood Glucose Devices Market Snippet by Patient Type
    • 2.1.5. Self-monitoring Blood Glucose Devices Market Snippet by End User
    • 2.1.6. Self-monitoring Blood Glucose Devices Market Snippet by Country
    • 2.1.7. Self-monitoring Blood Glucose Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Self-monitoring Blood Glucose Devices Key Market Trends

  • 3.1. Self-monitoring Blood Glucose Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Self-monitoring Blood Glucose Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Self-monitoring Blood Glucose Devices Market Opportunities
  • 3.4. Self-monitoring Blood Glucose Devices Market Future Trends

4. Self-monitoring Blood Glucose Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Self-monitoring Blood Glucose Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Self-monitoring Blood Glucose Devices Market Landscape

  • 6.1. Self-monitoring Blood Glucose Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Self-monitoring Blood Glucose Devices Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Self-Monitoring Blood Glucose (SMBG) Meters
    • 7.1.3. Test Strips
    • 7.1.4. Lancets
    • 7.1.5. Continuous Glucose Monitors

8. Self-monitoring Blood Glucose Devices Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Electrochemical
    • 8.1.3. Photometric

9. Self-monitoring Blood Glucose Devices Market - By Testing Site

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Testing Site, 2024 & 2032 (%)
    • 9.1.2. Fingertip
    • 9.1.3. Alternate Site Testing

10. Self-monitoring Blood Glucose Devices Market - By Patient Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Patient Type, 2024 & 2032 (%)
    • 10.1.2. Type 1 Diabetes
    • 10.1.3. Type 2 Diabetes
    • 10.1.4. Gestational Diabetes

11. Self-monitoring Blood Glucose Devices Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Ambulatory Surgery Centers
    • 11.1.4. Diagnostics Center
    • 11.1.5. Home Care
    • 11.1.6. Other

12. Self-monitoring Blood Glucose Devices Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Self-monitoring Blood Glucose Devices Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Self-monitoring Blood Glucose Devices Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Acon Laboratories, Inc.
    • 13.2.3. ARKRAY, Inc.
    • 13.2.4. Ascensia Diabetes Care
    • 13.2.5. B. Braun Melsungen AG
    • 13.2.6. Bayer AG
    • 13.2.7. Dexcom, Inc.
    • 13.2.8. Eli Lilly and Company
    • 13.2.9. GlucoMe
    • 13.2.10. i-SENS, Inc.
    • 13.2.11. LifeScan, Inc.
    • 13.2.12. Medtronic plc
    • 13.2.13. Nipro Corporation
    • 13.2.14. Nova Biomedical
    • 13.2.15. PHC Holdings Corporation
    • 13.2.16. Roche Diagnostics
    • 13.2.17. Sanofi
    • 13.2.18. Terumo Corporation
    • 13.2.19. Trividia Health, Inc.
    • 13.2.20. Ypsomed Holding AG

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us